• BIMS 6000

    Core Course in Integrative Biosciences
     Rating

     Difficulty

     GPA

    3.50

    Last Taught

    Fall 2026

    This course is designed to equip students with core concepts and fundamental skill sets needed for biomedical research. It combines traditional didactic lectures with small group and individual learning activities, problem solving exercises, workshops, and hands-on analyses of data sets. The course emphasizes the integration of topics spanning the fields of biochemistry, cell and molecular biology, and genetics.

  • BIMS 7100

    Research Ethics
     Rating

     Difficulty

     GPA

    Last Taught

    Spring 2026

    Beginning in 1989, the National Institutes of Health introduced a requirement that institutions provide a program of instruction in the responsible conduct of research (NIH Guide for Grants and Contracts, Volume 18, Number 45, 1989). This was later expanded to require that all fellows on NIH training grants should receive instruction in the responsible conduct of research. The requirement does not specify a particular format or curriculum. However, recommendations are made that several areas should be covered in the instruction: conflict of interest, responsible authorship, policies for handling misconduct, policies regarding the use of human and animal subjects, and data management. This course is designed to help student consider each of these areas and therein formulate an understanding of responsible conduct in research.

  • BIMS 8091

    CVRC Seminars
     Rating

     Difficulty

     GPA

    Last Taught

    Fall 2026

    CVRC Seminars

  • BIMS 8131

    Topics in the Molecular Basis of Human Disease
     Rating

     Difficulty

     GPA

    Last Taught

    Fall 2026

    A series of joint lectures by basic and clinical scientists that focus on the clinical context of a specific biomedical problem and the contemporary research that has resulted in major advances and treatment of the disease. Students participate in workshops on grantsmanship with coincident feedback on student's specific aims from faculty experts.

  • BIMS 8132

    Topics in the Molecular Basis of Human Disease
     Rating

     Difficulty

     GPA

    Last Taught

    Spring 2026

    A series of joint lectures by basic and clinical scientists that focus on the clinical context of a specific biomedical problem and the contemporary research that has resulted in major advances and treatment of the disease.

  • BIMS 8171

    M.D./Ph.D. Research in Progress Colloquium
     Rating

     Difficulty

     GPA

    4.00

    Last Taught

    Fall 2026

    The Research in Progress Colloquium is a series of research seminars and short talks by students in our combined M.D./Ph.D. Program. The major goals of the course are to familiarize students with key research areas of importance for training as physician scientists, and to develop the student's presentation skills. Students are required to give a minimum of one oral presentation per year to their fellow students and to selected faculty members who have expertise in the area of presentation. Students also are required to attend presentations of other students and to participate in group discussions. In addition to research presentations by students, there will also be presentations by faculty members in areas of significance for training of physician scientists. Grading (S/U) will be based on the quality of the students' presentation, as well as the extent of their participation in group discussions.

  • BIMS 8172

    MD/PhD Research in Progress Colloquium
     Rating

     Difficulty

     GPA

    Last Taught

    Spring 2026

    The Research in Progress Colloquium is a series of research seminars and short talks by students in our combined M.D./Ph.D. Program. The major goals of the course are to familiarize students with key research areas of importance for training as physician scientists, and to develop the student's presentation skills. Students are required to give a minimum of one oral presentation per year to their fellow students and to selected faculty members who have expertise in the area of presentation. Students also are required to attend presentations of other students and to participate in group discussions. In addition to research presentations by students, there will also be presentations by faculty members in areas of significance for training of physician scientists. Grading (S/U) will be based on the quality of the students' presentation, as well as the extent of their participation in group discussions.

  • BIMS 8380

    Practical Biomedical Statistics I
     Rating

     Difficulty

     GPA

    3.87

    Last Taught

    Fall 2026

    Students will learn the basic concepts, technology, and processes that guide the practical use of common statistical methods. The course introduces descriptive and inferential statistics and applications to real-world data. Students will reinforce learning with problem sets, a publicly sharable R portfolio, and a final project to achieve practical competence in the use of statistical software and interpretation of results.

  • BIMS 8382

    Practical Biomedical Statistics II
     Rating

     Difficulty

     GPA

    3.88

    Last Taught

    Fall 2026

    The course will expand students' statistical programming skills to utilize disparate datasets to generate conclusions about complex questions. Students will reinforce learning with problem sets and assignments to achieve competence in the use of statistical software to clean and organize data and apply the correct statistical approach (ANOVA, Chi-Square, regression, multiple regression) to interpret results.

  • BIMS 8401

    The Essentials of Translational Science
     Rating

     Difficulty

     GPA

    Last Taught

    Spring 2026

    The Translational Science Course is designed to prepare graduate students to engage in cutting-edge basic science discovery; understand proof-of-concept research and industrial designed experiments; innovate and invent; create valuable intellectual properties; optimize patent enablements and claims; interact with regulatory agencies; champion entrepreneurship and commercialization activities; and enhance societal impact of basic research.